BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29687681)

  • 21. HLA-B*5801 Testing to Prevent Allopurinol Hypersensitivity Syndrome: A Teachable Moment.
    Quach C; Galen BT
    JAMA Intern Med; 2018 Sep; 178(9):1260-1261. PubMed ID: 30083702
    [No Abstract]   [Full Text] [Related]  

  • 22. A first case of human herpesvirus-6B reactivation, confirmed by next-generation sequencing, in allopurinol-induced hypersensitivity syndrome in China.
    Xiao M; Qiao J; Wu C; Fan X; Cai-Ji ZM; Sun RX; Gong YP; Zhang YX; Wu HL; Kudinha T; Kong F; Jin HZ; Xu YC
    Eur J Dermatol; 2018 Oct; 28(5):698-699. PubMed ID: 30406757
    [No Abstract]   [Full Text] [Related]  

  • 23. HLA-B*5801: a genetic susceptibility to allopurinol-induced DRESS.
    Mugwagwa AN; Fischer R; Zailan I
    Med J Aust; 2016 Mar; 204(4):159-60. PubMed ID: 26937673
    [No Abstract]   [Full Text] [Related]  

  • 24. Allopurinol hypersensitivity and DRESS syndrome.
    Markel A
    Am J Med; 2008 Oct; 121(10):e25; author reply e27. PubMed ID: 18823840
    [No Abstract]   [Full Text] [Related]  

  • 25. Cerebral vasculitis and multi-focal neurological deficits due to allopurinol-induced hypersensitivity syndrome.
    Lim D; Rademaker M; Asztely F; Ratnaweera M; Coltman G
    Australas J Dermatol; 2014 Feb; 55(1):84-7. PubMed ID: 23330880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allopurinol-induced recurrent DRESS syndrome: pathophysiology and treatment.
    Shalom R; Rimbroth S; Rozenman D; Markel A
    Ren Fail; 2008; 30(3):327-9. PubMed ID: 18350453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes.
    Min HK; Lee B; Kwok SK; Ju JH; Kim WU; Park YM; Park SH
    Korean J Intern Med; 2015 Jul; 30(4):521-30. PubMed ID: 26161019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug Reaction, Eosinophilia and Systemic Symptoms (DRESS) syndrome secondary to allopurinol with early lymphadenopathy and symptom relapse.
    Turney R; Skittrall JP; Donovan J; Agranoff D
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26438678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug reaction with eosinophilia and systemic symptoms presenting as leukoencephalopathy.
    Yang J; Wang G; Fu M
    J Dermatol; 2019 Aug; 46(8):e305-e307. PubMed ID: 30868617
    [No Abstract]   [Full Text] [Related]  

  • 30. Allopurinol-induced drug reaction with eosinophilia and systemic symptoms syndrome with recurrence.
    Yang DC; Chang CM
    J Am Geriatr Soc; 2010 Oct; 58(10):2043-4. PubMed ID: 20929487
    [No Abstract]   [Full Text] [Related]  

  • 31. Fever and exanthema in a young patient: drug reaction with eosinophilia and systemic symptoms due to allopurinol.
    Gallo Puelles F; Muñoz Jiménez A; Velloso Feijoó ML; Leon Garcia M; Rodriguez Montero S; Marenco de la Fuente JL
    Reumatol Clin; 2013; 9(6):379-80. PubMed ID: 23726774
    [No Abstract]   [Full Text] [Related]  

  • 32. Allopurinol-induced DRESS syndrome in an adolescent patient.
    Dewan AK; Quinonez RA
    Pediatr Dermatol; 2010; 27(3):270-3. PubMed ID: 19804493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
    Fernando SL
    Australas J Dermatol; 2014 Feb; 55(1):15-23. PubMed ID: 23866082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Febuxostat (Adenuric). Toxic epidermal necrolysis and severe hypersensitivity reactions added to the EU SPC.
    Prescrire Int; 2015 Jun; 24(161):153. PubMed ID: 26436167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [DRESS syndrome].
    Adamcová M; Šturdík I; Koller T; Payer J
    Vnitr Lek; 2016 Apr; 62(4):334-7. PubMed ID: 27250614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allopurinol-induced DRESS syndrome.
    Markel A
    Isr Med Assoc J; 2005 Oct; 7(10):656-60. PubMed ID: 16259349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study.
    Ortonne N; Valeyrie-Allanore L; Bastuji-Garin S; Wechsler J; de Feraudy S; Duong TA; Delfau-Larue MH; Chosidow O; Wolkenstein P; Roujeau JC
    Br J Dermatol; 2015 Jul; 173(1):50-8. PubMed ID: 25630796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist.
    Adwan MH
    Curr Rheumatol Rep; 2017 Jan; 19(1):3. PubMed ID: 28138822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The allopurinol hypersensitivity syndrome.
    Pluim HJ; van Deuren M; Wetzels JF
    Neth J Med; 1998 Mar; 52(3):107-10. PubMed ID: 9599967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Allopurinol-induced DRESS complicated by hemophagocytic lymphohistiocytosis].
    Korbi M; Youssef M; Ben Brahim H; Chaabane A; Mohamed M; Akkari H; Belhadjali H; Zili J
    Ann Dermatol Venereol; 2015 Dec; 142(12):767-70. PubMed ID: 25982828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.